Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Ovarian Neoplasms 1Lymphatic Metastasis 1Hemangioma, Capillary 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3Cisplatin 2tislelizumab 1radium Ra 223 dichloride 1peposertib 1encorafenib 1cabozantinib 1binimetinib 1avelumab 1alovudine 1X-Rays 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Propranolol 1Platinum Compounds 1Platinum 1Pemetrexed 1Nivolumab 1Laparoscopy 1Ipilimumab 1Gemcitabine 1DNA Mismatch Repair 1Conversion to Open Surgery 1Carboplatin 1CTLA-4 Antigen 1Blood Specimen Collection 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × Propranolol × 90 days × Clear all
NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Enrolling by invitation
12 enrolled

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡